Recurrent Plasmacytomas after Allografting in a Patient with Multiple Myeloma

被引:7
作者
Stawis, Allen N. [1 ]
Maennle, Diane [2 ]
Festuccia, Moreno [3 ]
Uddin, Zia [2 ]
Bruno, Benedetto [3 ]
机构
[1] St John Macomb Oakland Hosp, Dept Hematol & Oncol, Webber Canc Ctr, Warren, MI 48093 USA
[2] St John Macomb Oakland Hosp, Dept Clin Pathol, Warren, MI 48093 USA
[3] Univ Turin, Div Hematol, Via Genova 3, I-10126 Turin, Italy
关键词
D O I
10.1155/2012/168785
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Extramedullary recurrence in multiple myeloma patients has been reported after both autologous and allogeneic hematopoietic cell transplantation and, more recently, after treatment with so-called new drugs with potent antimyeloma activity. Only a very few sizable reports focused on its clinical presentation and its incidence, which may be highly underestimated, and most observations are based on single patients reported from several institutions. Given the unusual sites of recurrence, diagnosis may be rather difficult and delayed treatment may play a relevant role in prognosis. Here we report a case of a myeloma patient, initially treated with an allograft, who enjoyed an eleven-year disease-free remission with very good quality of life. She eventually relapsed first with an extramedullary plasmacytoma in the breast and, two years later, with a right atrial cardiac mass.
引用
收藏
页数:5
相关论文
共 23 条
[1]  
Alegre A, 2002, HAEMATOLOGICA, V87, P609
[2]  
Billecke L, 2012, ANTICANCER RES, V32, P2031
[3]  
Bradwell AR, 2010, SERUM FREE LIGHT CHA
[4]   Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma [J].
Bruno, Benedetto ;
Giaccone, Luiso ;
Sorasio, Roberto ;
Boccadoro, Mario .
SEMINARS IN HEMATOLOGY, 2009, 46 (02) :158-165
[5]   Allogeneic transplantation for multiple myeloma: late relapse may occur as localised lytic lesion/plasmacytoma despite ongoing molecular remission [J].
Byrne, JL ;
Fairbairn, J ;
Davy, B ;
Carter, IG ;
Bessell, EM ;
Russell, NH .
BONE MARROW TRANSPLANTATION, 2003, 31 (03) :157-161
[6]   Extramedullary relapse of multiple myeloma associated with a shift in secretion from intact immunoglobulin to light chains [J].
Dawson, Mark A. ;
Patil, Sushrut ;
Spencer, Andrew .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (01) :143-144
[7]   International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders [J].
Dispenzieri, A. ;
Kyle, R. ;
Merlini, G. ;
Miguel, J. S. ;
Ludwig, H. ;
Hajek, R. ;
Palumbo, A. ;
Jagannath, S. ;
Blade, J. ;
Lonial, S. ;
Dimopoulos, M. ;
Comenzo, R. ;
Einsele, H. ;
Barlogie, B. ;
Anderson, K. ;
Gertz, M. ;
Harousseau, J. L. ;
Attal, M. ;
Tosi, P. ;
Sonneveld, P. ;
Boccadoro, M. ;
Morgan, G. ;
Richardson, P. ;
Sezer, O. ;
Mateos, M. V. ;
Cavo, M. ;
Joshua, D. ;
Turesson, I. ;
Chen, W. ;
Shimizu, K. ;
Powles, R. ;
Rajkumar, S. V. ;
Durie, B. G. M. .
LEUKEMIA, 2009, 23 (02) :215-224
[8]   A 71-Year-Old Woman with Multiple Myeloma Status after Stem Cell Transplantation [J].
Donato, Leslie J. ;
Zeldenrust, Steven R. ;
Murray, David L. ;
Katzmann, Jerry A. .
CLINICAL CHEMISTRY, 2011, 57 (12) :1645-1648
[9]  
Durie B. G., 2006, LEUKEMIA, V20
[10]   International uniform response criteria for multiple myeloma (vol 20, pg 1467, 2006) [J].
Durie, B. G. M. ;
Harousseau, J-L ;
Miguel, J. S. ;
Blade, J. ;
Barlogie, B. ;
Anderson, K. ;
Gertz, M. ;
Dimopoulos, M. ;
Westin, J. ;
Sonneveld, P. ;
Ludwig, H. ;
Gahrton, G. ;
Beksac, M. ;
Crowley, J. ;
Belch, A. ;
Boccadaro, M. ;
Turesson, I. ;
Joshua, D. ;
Vesole, D. ;
Kyle, R. ;
Alexanian, R. ;
Tricot, G. ;
Attal, M. ;
Merlini, G. ;
Powles, R. ;
Richardson, P. ;
Shimizu, K. ;
Tosi, P. ;
Morgan, G. ;
Rajkumar, S. V. .
LEUKEMIA, 2007, 21 (05) :1134-1134